ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Adare Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Adare Pharmaceuticals, INC. (Adare Pharmaceuticals, INC. 401(k) Plan · EIN 31-0988732 · PN 003): $69.10M net assets, 491 active participants, and $17.64 per $10,000 (17.64 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAdare Pharmaceuticals, INC.
Filing IdentifierAdare Pharmaceuticals, INC. 401(k) Plan · EIN 31-0988732 · PN 003
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$69.10M
Active Participants491
Direct Admin Fee Rate$17.64 per $10,000 (17.64 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($417,816, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI